Pfizer-BioNTech

WHO has clarified that while the new strain is transmissible and has higher chances of mutating more frequently, it is not any more severe than the variants that came earlier to it, like the delta variant. Amid a number of speculations…

Pfizer and BioNTech's mRNA vaccine candidate shows 90% effectiveness rate in phase 3 trials; expects to supply vaccine doses globally by 2020. Since the news of an interim analysis by Pfizer and BioNTech’s vaccine candidate reporting to…

COVID-19 Vaccine Can Come Up By September 15th; But Will It Be Effective? The drugmakers competing fiercely for the launch of a COVID-19 vaccine and its effectiveness based on its early data are also engrossed in meeting the targets set…

India Will Start Making Coronavirus Vaccines From August; World's Biggest Vaccine Trial Starts The world is eagerly watching the race to produce the COVID-19 vaccine with Oxford University-AstraZeneca, Moderna and Pfizer-BioNTech…